Table 4.
Measurement | Sample type | Age (years) | Unit | Assay and comments |
---|---|---|---|---|
Full blood count | Whole blood | ≥1.5 | Multiple | Beckman Coulter LH700 (Years 1–8); Siemens Advia 2120 (Years 8–11). Performed at Addenbrooke's Hospital |
HbA1cb | Whole blood | ≥1.5 | mmol/mol | HPLC (Tosoh Automated Glycohemoglobin Analyser). Years 1–10. |
Performed at Addenbrooke's Hospital | ||||
C-reactive protein (CRP) | Serum | ≥1.5 | mg/L | Siemens Dimension RXL (Years 1–5), Xpand (Years 6–10), |
EXL200 (Year 11) clinical chemistry analysers (manufacturer’s method (extended range)). From Year 11 performed at CBAL | ||||
Ferritin | Plasma (Years 1–10), serum Year 11 | ≥1.5 | μg/L | Dade Behring immunonephelometry on Siemens BN ProSpec (Years 1–5), Siemens immunoturbidimetric method on Dimension |
Xpand (Years 6–10), EXL200 (Year 11) clinical chemistry analysers. From Year 11 performed at CBAL | ||||
Soluble transferrin receptor (sTfR) | Plasma | ≥7 | mg/ml | Enzyme immunoassay. Years 1–4 |
Creatinine | Plasma (Years 1–9), serum Year 10 | ≥1.5 | μmol/L | Siemens Dimension Xpand clinical chemistry analyser (manufacturer’s method). Changed from compensated kinetic Jaffe to enzymatic method during Year 9 |
Glucose (only if fasted)b | Plasma | ≥7 | mmol/L | Siemens Dimension Xpand clinical chemistry analyser (manufacturer’s method). Years 1–5 |
Total and HDL cholesterol, triglycerides | Serum | ≥1.5 | mmol/L | Siemens Dimension RXL (Years 1–5), Xpand (Years 6–10), |
EXL200 (Year 11) clinical chemistry analysers (manufacturer’s methods). From Year 11 performed at CBAL | ||||
LDL cholesterol | Serum | ≥1.5 | mmol/L | Calculated (Friedewald equation) |
Thiamin (vitamin B1) | Red blood cell haemolysates | ≥1.5 | n/a | ETKAC |
Riboflavin (vitamin B2) | Red blood cell haemolysates | ≥1.5 | n/a | EGRAC |
Vitamin B6 (pyridoxal-5-phosphate and pyridoxic acid) | Plasma | ≥1.5 | nmol/L | HPLC with fluorimetric detection |
Vitamin B12 | Serum | ≥1.5 | ng/L | Siemens Advia Centaur (manufacturer’s competitive protein binding method). Performed at Addenbrooke's Hospital |
Holo-transcobalamin | Serum | ≥1.5 | pmol/L | ELISA (Axis Shield Diagnostics, Dundee). Years 6–11 |
Homocysteine | Plasma | ≥7 | μmol/L | Immunoturbidimetric assay on Siemens BN ProSpec (manufacturer’s method). Years 1–5 |
Folate | Serum | ≥1.5 | nmol/L | LC-MS/MS (During Years 1–6 performed at CDC) |
Whole blood folate | Whole blood | ≥1.5 | nmol/L | Microbiological method, performed at CDC. Red cell folate is calculated from whole blood folate, serum folate and haematocrit. |
Vitamin C | Plasma | ≥1.5 | μmol/L | Fluorescent enzymatic assay |
Retinol (vitamin A), retinyl palmitate, α-tocopherol, γ-tocopherol (vitamin E), α- and β-cryptoxanthin, lycopene, lutein and zeaxanthin (combined), α- and β –carotene | Plasma | ≥1.5 | μmol/L | HPLC with photodiode array detection. Retinyl palmitate measured in Years 1–4 only |
Vitamin D (25-hydroxyvitamin D) | Serum | ≥1.5 | nmol/L | CLIA (DiaSorin Liaison (Years 1–6)). LC-MS/MS (Years 7–11) |
Selenium and zinc | Plasma (Years 1–10), serum Year 11 | ≥7 | μmol/L | Inductively coupled plasma mass spectrometry (ICP-MS). From |
Year 11, performed at University Hospital Southampton. Measured in all ages from Year 11 | ||||
Repository samples | Plasma/serum | ≥1.5 | n/a |
CBAL, Core Biochemical Assay Laboratory, Addenbrooke's Hospital; CDC, Centers for Disease Control; CLIA, Chemiluminescence immunoassay; EGRAC, erythrocyte gluthathione reductase activation coefficient; ELISA, enzyme-linked immunosorbent assay; ETKAC, erythrocyte transketolase activation coefficient; HbA1c, glycated haemoglobin; HDL, high density lipoprotein; HPLC, high performance liquid chromatography; LC-MS/MS, liquid chromatography tandem mass spectrometry; LDL, low density lipoprotein [Friedewald equation: LDL = Total cholesterol – HDL cholesterol – (triglycerides/2.2)].
Analyses were peformed at Medical Research Council Elsie Widdowson Laboratory (Years 1–10) or Nutritional Biomarker Laboratory, MRC Epidemiology Unit (Year 11 onwards) unless otherwise stated.
Analysis of these analytes was funded separately by Diabetes UK.